Cefepime: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
Cefepime is a fourth-generation [[cephalosporin]] antibiotic. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both types of organism than third-generation agents. A 2007 meta-analysis suggested when data of trials were combined, mortality was increased in people treated with cefepime compared with other β-lactam antibiotics. <ref name="a1">PMID:17448937</ref> [https://en.wikipedia.org/wiki/Cefepime Cefepime]. | Cefepime is a fourth-generation [[cephalosporin]] antibiotic. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both types of organism than third-generation agents. A 2007 meta-analysis suggested when data of trials were combined, mortality was increased in people treated with cefepime compared with other β-lactam antibiotics. <ref name="a1">PMID:17448937</ref> [https://en.wikipedia.org/wiki/Cefepime Cefepime]. | ||
[[5oj0]]. | <scene name='10/1040142/Cv/2'>Penicillin-Binding Protein 2X (PBP2X) from Streptococcus pneumoniae in complex with Cefepime</scene> ([[5oj0]]). | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||